To Evaluate the Safety, Tolerance and Pharmacokinetics of BAT8007 for Injection in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Advanced Solid Tumors
Related studies linked through entity extraction aliases.
HV-101 for Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Safety, Tolerability, Pharmacokinetics (PK), and Primary Clinical Efficacy of LY01616 in Patients With Advanced Solid Tumors
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1/PHASE2
Study of ZGGS15 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Study of PM1003 in Phase I/IIa Treatment of Advanced Malignant Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A First-in-human Study to Learn How Safe the Study Treatment BAY2862789 is, to Find the Best Dose, How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, and How it Acts on Different Tumors in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001)
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Phase I Study of QLP2117 in Subjects With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Clinical Study of IMP4297 Capsule (JS109) Combined With Irinotecan in the Treatment of Advanced Malignant Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study Evaluates the Safety, Pharmacokinetics, Immunogenicity and Efficacy of QLS31903 in Advanced Solid Tumor Patients
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Evidence of Antitumor Activity of FHND5071 as a Single Agent in Adult Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of KM501 in Patients With Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Clinical Study of the Safety， Tolerability，Pharmacokinetics, and Initial Efficacy of HRS-6209 Monotherapy in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
The Primary Objective of This Study to Evaluate the Safety and Tolerability of IBI334 and Determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D)and Anti Tumor Activity of IBI334.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study Explore WJB001 Capsules in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of GEC255 in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation
- Status
- UNKNOWN
- Phase
- PHASE1